Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > The buyout will be
View:
Post by O12009 on Jan 21, 2021 12:02pm

The buyout will be

This company will sell for 8 billion in April of 2022. This will be the result of a bidding war.
Comment by StevenBirch on Jan 21, 2021 12:29pm
Sounds good. Can we get back to pre-financing levels bt the time they add 4 more sites in the U.S.? Hopefully that can happen in the next few weeks to couple of months. The enrollment numbers should really start to pick up and then by the time we start getting meaningful results we could get that decimal place moved over - hopefully $3 - $4 by mid to late summer? I like your timeline but with ...more  
Comment by robertshaw on Jan 21, 2021 12:30pm
The bullshitliar style scam of Elizabeth Holmes could be appraised for 9 billon dollars, but not for this technology of curing all kind of cancers and covid virus... Blowjobjoe's f?cking bosses won't allow 8 billon buyout target to be reached.... So, Our deadly enemy are Blowjobjoe's bosses (anonymous1)..
Comment by BencrosMum on Jan 21, 2021 12:56pm
US or CAD?
Comment by O12009 on Jan 21, 2021 1:27pm
 
Comment by BencrosMum on Jan 21, 2021 2:11pm
Do you mind elaborating on how you came to this scenario? you're from the future? No offense but pretty much every prediction on tlt I've ever seen has fallen flat :). Not trying to be mean! I would love for it to be true   
Comment by Bunge on Jan 21, 2021 2:28pm
After 8 years of that I'm kinda tired of it too.
Comment by floatinketucky on Jan 21, 2021 10:31pm
If the CR rates are confirmed over 60 percent, the PPS should breakout of our 5 year range.    Once treating patients in the USA, with unprecedented CR rates what happens when we get National US news coverage??     Perhaps a drive to 3 dollars US.    This would consider the power of momentum. The chart may look very similar to CYDY.   ...more  
Comment by charlierock on Jan 21, 2021 10:45pm
Once Theralase is featured on a segment of 60 minutes......the stock price will be in the stratosphere.....one can only dream
Comment by floatinketucky on Jan 21, 2021 11:11pm
I consider a small segment on a national program reasonable. 
Comment by Rumpl3StiltSkin on Jan 21, 2021 3:16pm
Mom, I think given some of the past scenarios considered, to give TLT a $8Bill US  or higher value, would only take the NMIBC and a cpl of other Cancer indications in the mix as phase 1s. Thus making TLT a multi indication cancer play. O'course now we also have the Covid 19 angle. Huge potential for a buyout IMO and all due to happen by April 2022. Or maybe O12009 is Nostradamus?
Comment by Rumpl3StiltSkin on Jan 21, 2021 3:18pm
And Mom, It was originally your son who worked out some of those early $$ valuation scenarios. I think many here agreed with them back then.
Comment by O12009 on Jan 21, 2021 4:03pm
https://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwj5pf_89a3uAhWZSjABHc83AXcQFjABegQIBhAC&url=https%3A%2F%2Fwww.eurekalert.org%2Fpub_releases%2F2006-04%2Fuocp-cfc042606.php&usg=AOvVaw256zXvkwhKIlxQwCptMQlA   And this does not include the cure for many viruses that we have no way of treating  
Comment by O12009 on Jan 21, 2021 6:26pm
  This is so true Benco along with Hempdoc, Macer ( who only recently came back) Eoganacht, Cancer Slayer, enriquesuave, Yajne,etc etc etc this was by far the greatest bullboard on Stockhouse. The information they shared here was second to none.
Comment by CancerSlayer on Jan 21, 2021 2:15pm
  TBH, it's too hard to put a price on our ACT.  TLT is not only a unique player, our uniqueness is still evolving.  The price tag could grow significantly, depending on the degree/type of further modifications made.  If TLT is able to solve the "deep-seated" tumor challenge (i.e. compound activation via simpler methods....x-ray, etc.), this could easily double ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250